Categories: Health Care

NEC: Northgate Public Services Makes Three Acquisitions to Strengthen its International Healthcare Screening Offering

London, April 05, 2019 : NEC Corporation (TSE: 6701) and Northgate Public Services (NPS), a wholly owned NEC subsidiary, today announced that NPS acquired three EMIS Group plc businesses for POUND14.9 million, to strengthen its growing screening and preventative healthcare offering.

The three acquired EMIS Group plc businesses, Digital Healthcare Limited, Medical Imaging UK Limited and MIDRSS Limited, have 25 years’ experience in diabetic eye screening, assessing around 50,000 patients every month in 1,200 different locations.

NPS already has a significant presence in this sector, helping to screen 10 million babies for the Newborn Hearing Screening Program in England and Northern Ireland and testing 500,000 patients with diabetes for retina damage and sight loss under Scotland’s Diabetic Screening Programme. These acquisitions will give NPS a screening presence in eight countries across the globe, including the rapidly growing healthcare market in India.

The total cash consideration for the acquisition was POUND 14.9 million, made up of ?14 million paid on completion (inclusive of POUND 5 million of inter company debtor balances settled in cash by EMIS Group on completion) and POUND 0.9 million of contingent consideration.

Stephen Callaghan, chief executive officer of NPS, said, “Uniting our extensive experience in healthcare screening will bring the best possible preventative technology and care to the public, initially in the UK and subsequently in other parts of the world. We are very proud of our existing screening programmes in UK, Ireland and India and are very much looking forward to extending our offering to secure the best possible patient outcomes. Preventative measures, such as screening, will have an increasing role to play in improving health in both the UK and worldwide.”

Lydia Saunders, director and general manager of EMIS Care, said, “Joining the NPS team brings new and exciting prospects for the detection and prevention of serious health conditions to protect the public internationally.”

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

32 mins ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

18 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

3 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago